Researchers explored data from the GALACTIC-HF trial to evaluate how the severity of a patient's reduced ejection fraction impacts the benefits of omecamtiv mecarbil.
Anthony S. Fauci, MD, a central figure in the White House Coronavirus Task Force, spoke at length about COVID-19 during the AHA's Scientific Sessions 2020 virtual meeting.
The role of ACE inhibitors and ARBs in the treatment of COVID-19 has been a key topic for researchers since the pandemic began. This latest research represents a significant update for clinicians.